FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035379871> ?p ?o ?g. }

• W2035379871 abstract "Niacin has proven lipid-modifying efficacy and cardiovascular benefit; however, it is underused because of skin flushing, a process mediated primarily by prostaglandin D(2) (PGD(2)). Laropiprant (LRPT), a PGD(2) receptor (DP1) antagonist that mitigates niacin-induced flushing, has been combined with extended-release niacin (ERN) into a fixed-dose tablet containing 1g of ERN and 20mg of LRPT (ERN/LRPT 1g). In a large-scale (n=∼1600), multinational, 6-month study in dyslipidemic patients, ERN/LRPT 2g produced superior lipid-modifying efficacy vs placebo, whether administered alone or with concomitant statins.This Phase III, randomized, double-blind study evaluated the lipid-modifying efficacy of ERN/LRPT alone or added to ongoing statins in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia.After a 4-week placebo run-in, patients were randomized to ERN/LRPT 1g (n=322) or placebo (PBO; n=324). After 4 weeks, the dose was advanced to 2 tablets/d (ERN/LRPT 2g or PBO) for 8 additional weeks. End points included effects of ERN/LRPT 2g vs PBO on low-density lipoprotein cholesterol (LDL-C; primary), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), and other lipids/lipoproteins.Relative to PBO, ERN/LRPT 2g produced significant (P < .001) changes in LDL-C (-14.7%), HDL-C (15.9%), TG (-23.4%), LDL-C:HDL-C (-25.5%), non-HDL-C (-16.4%), apolipoprotein (Apo) B (-15.4%), and Apo A-I (5.3%) from baseline to week 12 in the total population. Similar results were observed in patients treated with ERN/LRPT alone or added to ongoing statin.ERN/LRPT 2g, administered alone or with a statin, produced significant improvements in multiple lipid/lipoprotein parameters in dyslipidemic Asian patients." @default.
• W2035379871 created "2016-06-24" @default.
• W2035379871 creator A5012050263 @default.
• W2035379871 creator A5021579570 @default.
• W2035379871 creator A5021696521 @default.
• W2035379871 creator A5043890607 @default.
• W2035379871 creator A5045361973 @default.
• W2035379871 creator A5049225160 @default.
• W2035379871 creator A5053319727 @default.
• W2035379871 creator A5057080887 @default.
• W2035379871 creator A5067906247 @default.
• W2035379871 date "2009-05-01" @default.
• W2035379871 modified "2023-10-05" @default.
• W2035379871 title "Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia" @default.
• W2035379871 cites W1481564277 @default.
• W2035379871 cites W1505444180 @default.
• W2035379871 cites W1966591614 @default.
• W2035379871 cites W1990598691 @default.
• W2035379871 cites W2010047125 @default.
• W2035379871 cites W2021515095 @default.
• W2035379871 cites W2044810423 @default.
• W2035379871 cites W2046991199 @default.
• W2035379871 cites W2048244406 @default.
• W2035379871 cites W2070855777 @default.
• W2035379871 cites W2103682415 @default.
• W2035379871 cites W2109386122 @default.
• W2035379871 cites W2115572248 @default.
• W2035379871 cites W2119065130 @default.
• W2035379871 cites W2124892367 @default.
• W2035379871 cites W2160420401 @default.
• W2035379871 cites W2160689800 @default.
• W2035379871 cites W2169033201 @default.
• W2035379871 cites W2477872031 @default.
• W2035379871 cites W2725187802 @default.
• W2035379871 cites W85975945 @default.
• W2035379871 doi "https://doi.org/10.1016/j.jacl.2009.04.048" @default.
• W2035379871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21291812" @default.
• W2035379871 hasPublicationYear "2009" @default.
• W2035379871 type Work @default.
• W2035379871 sameAs 2035379871 @default.
• W2035379871 citedByCount "3" @default.
• W2035379871 countsByYear W20353798712013 @default.
• W2035379871 countsByYear W20353798712015 @default.
• W2035379871 crossrefType "journal-article" @default.
• W2035379871 hasAuthorship W2035379871A5012050263 @default.
• W2035379871 hasAuthorship W2035379871A5021579570 @default.
• W2035379871 hasAuthorship W2035379871A5021696521 @default.
• W2035379871 hasAuthorship W2035379871A5043890607 @default.
• W2035379871 hasAuthorship W2035379871A5045361973 @default.
• W2035379871 hasAuthorship W2035379871A5049225160 @default.
• W2035379871 hasAuthorship W2035379871A5053319727 @default.
• W2035379871 hasAuthorship W2035379871A5057080887 @default.
• W2035379871 hasAuthorship W2035379871A5067906247 @default.
• W2035379871 hasConcept C126322002 @default.
• W2035379871 hasConcept C134018914 @default.
• W2035379871 hasConcept C142724271 @default.
• W2035379871 hasConcept C204787440 @default.
• W2035379871 hasConcept C27081682 @default.
• W2035379871 hasConcept C2778163477 @default.
• W2035379871 hasConcept C2778913445 @default.
• W2035379871 hasConcept C2779091943 @default.
• W2035379871 hasConcept C2779120738 @default.
• W2035379871 hasConcept C2780092750 @default.
• W2035379871 hasConcept C2908647359 @default.
• W2035379871 hasConcept C555293320 @default.
• W2035379871 hasConcept C62746215 @default.
• W2035379871 hasConcept C71924100 @default.
• W2035379871 hasConcept C90924648 @default.
• W2035379871 hasConcept C98274493 @default.
• W2035379871 hasConcept C99454951 @default.
• W2035379871 hasConceptScore W2035379871C126322002 @default.
• W2035379871 hasConceptScore W2035379871C134018914 @default.
• W2035379871 hasConceptScore W2035379871C142724271 @default.
• W2035379871 hasConceptScore W2035379871C204787440 @default.
• W2035379871 hasConceptScore W2035379871C27081682 @default.
• W2035379871 hasConceptScore W2035379871C2778163477 @default.
• W2035379871 hasConceptScore W2035379871C2778913445 @default.
• W2035379871 hasConceptScore W2035379871C2779091943 @default.
• W2035379871 hasConceptScore W2035379871C2779120738 @default.
• W2035379871 hasConceptScore W2035379871C2780092750 @default.
• W2035379871 hasConceptScore W2035379871C2908647359 @default.
• W2035379871 hasConceptScore W2035379871C555293320 @default.
• W2035379871 hasConceptScore W2035379871C62746215 @default.
• W2035379871 hasConceptScore W2035379871C71924100 @default.
• W2035379871 hasConceptScore W2035379871C90924648 @default.
• W2035379871 hasConceptScore W2035379871C98274493 @default.
• W2035379871 hasConceptScore W2035379871C99454951 @default.
• W2035379871 hasLocation W20353798711 @default.
• W2035379871 hasLocation W20353798712 @default.
• W2035379871 hasOpenAccess W2035379871 @default.
• W2035379871 hasPrimaryLocation W20353798711 @default.
• W2035379871 hasRelatedWork W1265589548 @default.
• W2035379871 hasRelatedWork W2013998010 @default.
• W2035379871 hasRelatedWork W2023333646 @default.
• W2035379871 hasRelatedWork W2025648868 @default.
• W2035379871 hasRelatedWork W2035484352 @default.
• W2035379871 hasRelatedWork W2155947160 @default.
• W2035379871 hasRelatedWork W2350174576 @default.
• W2035379871 hasRelatedWork W2418228134 @default.
• W2035379871 hasRelatedWork W2607435969 @default.

• next